Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.41
Delayed Data
As of Jun 27
 -0.13 / -8.44%
Today’s Change
1.23
Today|||52-Week Range
20.45
-86.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash37.2M61.0M375.9M90.0M
 
 
 
 
 
Short Term Investment Cash10.8M23.7M314.9M-311.4M
 
 
 
 
 
Cash & Short Term Investments82.2M126.2M375.9M90.0M
 
 
 
 
 
 
ReceivablesReceivables0.007.6M17.1M13.6M
 
 
 
 
 
InventoriesInventories0.001.6M9.5M58.7M
 
 
 
 
 
Current AssetsOther Current Assets1.6M5.1M4.9M13.6M
 
 
 
 
 
Current Assets83.7M140.5M407.4M175.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.4M2.4M6.7M8.5M
 
 
 
 
 
Depreciation-276.0K-745.0K-2.0M-3.6M
 
 
 
 
 
Intangible Assets--0.00--252.5M
 
 
Other Assets93.0K164.0K5.3M253.4M
 
 
 
 
 
Total Assets85.2M142.3M417.5M434.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.0M4.1M9.7M10.8M
 
 
 
 
 
Short Term Debt3.0M3.6M3.5M25.0M
 
 
 
 
 
Accrued Expenses4.8M9.4M19.5M40.8M
 
 
 
 
 
Other Current Liabilities4.8M9.4M19.5M40.8M
 
 
 
 
 
Other Liabilities16.9M24.8M39.8M86.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt7.6M4.0M215.4M229.8M
 
 
 
 
 
Other Liabilities173.0K445.0K1.9M2.0M
 
 
 
 
 
Total Liabilities24.7M29.3M257.2M318.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity60.5M113.0M160.3M115.5M
 
 
 
 
 
Total Shareholder Equity60.5M113.0M160.3M115.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding25.5M29.4M28.5M29.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.